Index by author

Proceedings of the 1st World Congress on Controversies in Diabetes, Obesity and Hypertension (CODHy)

February 01 2008; volume 31 issue Supplement 2

B

  1. Basi, Seema

    1. Microalbuminuria in Type 2 Diabetes and HypertensionA marker, treatment target, or innocent bystander?
      Seema Basi, Pierre Fesler, Albert Mimran and Julia B. Lewis
      Diabetes Care 2008 Feb; 31 (Supplement 2): S194-S201. https://doi.org/10.2337/dc08-s249

  2. Beattie, Scott D.

    1. Natural History of Cardiovascular Disease in Patients With DiabetesRole of hyperglycemia
      Zvonko Milicevic, Itamar Raz, Scott D. Beattie, Barbara N. Campaigne, Samiha Sarwat, Elwira Gromniak, Irina Kowalska, Edvard Galic, Meng Tan and Markolf Hanefeld
      Diabetes Care 2008 Feb; 31 (Supplement 2): S155-S160. https://doi.org/10.2337/dc08-s240

  3. Bianchi, Cristina

    1. Primary Prevention of Cardiovascular Disease in People With Dysglycemia
      Cristina Bianchi, Roberto Miccoli, Giuseppe Penno and Stefano Del Prato
      Diabetes Care 2008 Feb; 31 (Supplement 2): S208-S214. https://doi.org/10.2337/dc08-s256

  4. Bloom, Stephen R.

    1. Can Gut Hormones Control Appetite and Prevent Obesity?
      Owais B. Chaudhri, Katie Wynne and Stephen R. Bloom
      Diabetes Care 2008 Feb; 31 (Supplement 2): S284-S289. https://doi.org/10.2337/dc08-s269

  5. Bolli, Geremia B.

    1. Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 DiabetesThe role of insulin analogs
      Paolo Rossetti, Francesca Porcellati, Geremia B. Bolli and Carmine G. Fanelli
      Diabetes Care 2008 Feb; 31 (Supplement 2): S113-S120. https://doi.org/10.2337/dc08-s227

  6. Brendel, Mathias D.

    1. Is Pancreatic Diabetes (Type 3c Diabetes) Underdiagnosed and Misdiagnosed?
      Philip D. Hardt, Mathias D. Brendel, Hans U. Kloer and Reinhard G. Bretzel
      Diabetes Care 2008 Feb; 31 (Supplement 2): S165-S169. https://doi.org/10.2337/dc08-s244

  7. Bretzel, Reinhard G.

    1. Is Pancreatic Diabetes (Type 3c Diabetes) Underdiagnosed and Misdiagnosed?
      Philip D. Hardt, Mathias D. Brendel, Hans U. Kloer and Reinhard G. Bretzel
      Diabetes Care 2008 Feb; 31 (Supplement 2): S165-S169. https://doi.org/10.2337/dc08-s244

C

  1. Campaigne, Barbara N.

    1. Natural History of Cardiovascular Disease in Patients With DiabetesRole of hyperglycemia
      Zvonko Milicevic, Itamar Raz, Scott D. Beattie, Barbara N. Campaigne, Samiha Sarwat, Elwira Gromniak, Irina Kowalska, Edvard Galic, Meng Tan and Markolf Hanefeld
      Diabetes Care 2008 Feb; 31 (Supplement 2): S155-S160. https://doi.org/10.2337/dc08-s240

  2. Ceriello, Antonio

    1. Possible Role of Oxidative Stress in the Pathogenesis of Hypertension
      Antonio Ceriello
      Diabetes Care 2008 Feb; 31 (Supplement 2): S181-S184. https://doi.org/10.2337/dc08-s245

  3. Chaudhri, Owais B.

    1. Can Gut Hormones Control Appetite and Prevent Obesity?
      Owais B. Chaudhri, Katie Wynne and Stephen R. Bloom
      Diabetes Care 2008 Feb; 31 (Supplement 2): S284-S289. https://doi.org/10.2337/dc08-s269

  4. Colette, Claude

    1. Glycemic VariabilityShould we and can we prevent it?
      Louis Monnier and Claude Colette
      Diabetes Care 2008 Feb; 31 (Supplement 2): S150-S154. https://doi.org/10.2337/dc08-s241

D

  1. Dankner, Rachel

    1. Insulin Resistance and HyperinsulinemiaIs hyperinsulinemia the cart or the horse?
      Michael H. Shanik, Yuping Xu, Jan Škrha, Rachel Dankner, Yehiel Zick and Jesse Roth
      Diabetes Care 2008 Feb; 31 (Supplement 2): S262-S268. https://doi.org/10.2337/dc08-s264

  2. Del Prato, Stefano

    1. Primary Prevention of Cardiovascular Disease in People With Dysglycemia
      Cristina Bianchi, Roberto Miccoli, Giuseppe Penno and Stefano Del Prato
      Diabetes Care 2008 Feb; 31 (Supplement 2): S208-S214. https://doi.org/10.2337/dc08-s256

  3. Després, Jean-Pierre

    1. Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese PatientsPooled 1-year data from the Rimonabant in Obesity (RIO) program
      Luc Van Gaal, Xavier Pi-Sunyer, Jean-Pierre Després, Christine McCarthy and André Scheen
      Diabetes Care 2008 Feb; 31 (Supplement 2): S229-S240. https://doi.org/10.2337/dc08-s258

  4. de Zeeuw, Dick

    1. Albuminuria: A Great Risk Marker, but an Underestimated Target in Diabetes
      Dick de Zeeuw and Itamar Raz
      Diabetes Care 2008 Feb; 31 (Supplement 2): S190-S193. https://doi.org/10.2337/dc08-s248

  5. Donath, Marc Y.

    1. Islet Inflammation in Type 2 DiabetesFrom metabolic stress to therapy
      Marc Y. Donath, Desiree M. Schumann, Mirjam Faulenbach, Helga Ellingsgaard, Aurel Perren and Jan A. Ehses
      Diabetes Care 2008 Feb; 31 (Supplement 2): S161-S164. https://doi.org/10.2337/dc08-s243

E

  1. Ehses, Jan A.

    1. Islet Inflammation in Type 2 DiabetesFrom metabolic stress to therapy
      Marc Y. Donath, Desiree M. Schumann, Mirjam Faulenbach, Helga Ellingsgaard, Aurel Perren and Jan A. Ehses
      Diabetes Care 2008 Feb; 31 (Supplement 2): S161-S164. https://doi.org/10.2337/dc08-s243

  2. Ellingsgaard, Helga

    1. Islet Inflammation in Type 2 DiabetesFrom metabolic stress to therapy
      Marc Y. Donath, Desiree M. Schumann, Mirjam Faulenbach, Helga Ellingsgaard, Aurel Perren and Jan A. Ehses
      Diabetes Care 2008 Feb; 31 (Supplement 2): S161-S164. https://doi.org/10.2337/dc08-s243

F

  1. Fanelli, Carmine G.

    1. Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 DiabetesThe role of insulin analogs
      Paolo Rossetti, Francesca Porcellati, Geremia B. Bolli and Carmine G. Fanelli
      Diabetes Care 2008 Feb; 31 (Supplement 2): S113-S120. https://doi.org/10.2337/dc08-s227

  2. Faulenbach, Mirjam

    1. Islet Inflammation in Type 2 DiabetesFrom metabolic stress to therapy
      Marc Y. Donath, Desiree M. Schumann, Mirjam Faulenbach, Helga Ellingsgaard, Aurel Perren and Jan A. Ehses
      Diabetes Care 2008 Feb; 31 (Supplement 2): S161-S164. https://doi.org/10.2337/dc08-s243

  3. Fesler, Pierre

    1. Microalbuminuria in Type 2 Diabetes and HypertensionA marker, treatment target, or innocent bystander?
      Seema Basi, Pierre Fesler, Albert Mimran and Julia B. Lewis
      Diabetes Care 2008 Feb; 31 (Supplement 2): S194-S201. https://doi.org/10.2337/dc08-s249

G

  1. Galic, Edvard

    1. Natural History of Cardiovascular Disease in Patients With DiabetesRole of hyperglycemia
      Zvonko Milicevic, Itamar Raz, Scott D. Beattie, Barbara N. Campaigne, Samiha Sarwat, Elwira Gromniak, Irina Kowalska, Edvard Galic, Meng Tan and Markolf Hanefeld
      Diabetes Care 2008 Feb; 31 (Supplement 2): S155-S160. https://doi.org/10.2337/dc08-s240

  2. Gitt, Anselm K.

    1. Should We Prescribe Statin and Aspirin for Every Diabetic Patient?Is it time for a polypill?
      Harm Wienbergen, Jochen Senges and Anselm K. Gitt
      Diabetes Care 2008 Feb; 31 (Supplement 2): S222-S225. https://doi.org/10.2337/dc08-s253

  3. Gromniak, Elwira

    1. Natural History of Cardiovascular Disease in Patients With DiabetesRole of hyperglycemia
      Zvonko Milicevic, Itamar Raz, Scott D. Beattie, Barbara N. Campaigne, Samiha Sarwat, Elwira Gromniak, Irina Kowalska, Edvard Galic, Meng Tan and Markolf Hanefeld
      Diabetes Care 2008 Feb; 31 (Supplement 2): S155-S160. https://doi.org/10.2337/dc08-s240

  4. Grossman, Ehud

    1. Does Increased Oxidative Stress Cause Hypertension?
      Ehud Grossman
      Diabetes Care 2008 Feb; 31 (Supplement 2): S185-S189. https://doi.org/10.2337/dc08-s246

H

  1. Hainer, Vojtĕch

    1. Treatment Modalities of ObesityWhat fits whom?
      Vojtĕch Hainer, Hermann Toplak and Asimina Mitrakou
      Diabetes Care 2008 Feb; 31 (Supplement 2): S269-S277. https://doi.org/10.2337/dc08-s265

  2. Hanefeld, Markolf

    1. Natural History of Cardiovascular Disease in Patients With DiabetesRole of hyperglycemia
      Zvonko Milicevic, Itamar Raz, Scott D. Beattie, Barbara N. Campaigne, Samiha Sarwat, Elwira Gromniak, Irina Kowalska, Edvard Galic, Meng Tan and Markolf Hanefeld
      Diabetes Care 2008 Feb; 31 (Supplement 2): S155-S160. https://doi.org/10.2337/dc08-s240

  3. Hardt, Philip D.

    1. Is Pancreatic Diabetes (Type 3c Diabetes) Underdiagnosed and Misdiagnosed?
      Philip D. Hardt, Mathias D. Brendel, Hans U. Kloer and Reinhard G. Bretzel
      Diabetes Care 2008 Feb; 31 (Supplement 2): S165-S169. https://doi.org/10.2337/dc08-s244

K

  1. Kaufman, Francine Ratner

    1. Metabolic Complications of Childhood ObesityIdentifying and mitigating the risk
      Ram Weiss and Francine Ratner Kaufman
      Diabetes Care 2008 Feb; 31 (Supplement 2): S310-S316. https://doi.org/10.2337/dc08-s273

  2. Kloer, Hans U.

    1. Is Pancreatic Diabetes (Type 3c Diabetes) Underdiagnosed and Misdiagnosed?
      Philip D. Hardt, Mathias D. Brendel, Hans U. Kloer and Reinhard G. Bretzel
      Diabetes Care 2008 Feb; 31 (Supplement 2): S165-S169. https://doi.org/10.2337/dc08-s244

  3. Kowalska, Irina

    1. Natural History of Cardiovascular Disease in Patients With DiabetesRole of hyperglycemia
      Zvonko Milicevic, Itamar Raz, Scott D. Beattie, Barbara N. Campaigne, Samiha Sarwat, Elwira Gromniak, Irina Kowalska, Edvard Galic, Meng Tan and Markolf Hanefeld
      Diabetes Care 2008 Feb; 31 (Supplement 2): S155-S160. https://doi.org/10.2337/dc08-s240

L

  1. Lewis, Edmund J.

    1. Abnormal Glomerular Permeability Characteristics in Diabetic NephropathyImplications for the therapeutic use of low–molecular weight heparin
      Edmund J. Lewis and Xiulong Xu
      Diabetes Care 2008 Feb; 31 (Supplement 2): S202-S207. https://doi.org/10.2337/dc08-s251

  2. Lewis, Julia B.

    1. Microalbuminuria in Type 2 Diabetes and HypertensionA marker, treatment target, or innocent bystander?
      Seema Basi, Pierre Fesler, Albert Mimran and Julia B. Lewis
      Diabetes Care 2008 Feb; 31 (Supplement 2): S194-S201. https://doi.org/10.2337/dc08-s249

M

  1. Massi-Benedetti, Massimo

    1. Treatment of Type 2 Diabetes With Combined TherapyWhat are the pros and cons?
      Massimo Massi-Benedetti and Marco Orsini-Federici
      Diabetes Care 2008 Feb; 31 (Supplement 2): S131-S135. https://doi.org/10.2337/dc08-s233

  2. McCarthy, Christine

    1. Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese PatientsPooled 1-year data from the Rimonabant in Obesity (RIO) program
      Luc Van Gaal, Xavier Pi-Sunyer, Jean-Pierre Després, Christine McCarthy and André Scheen
      Diabetes Care 2008 Feb; 31 (Supplement 2): S229-S240. https://doi.org/10.2337/dc08-s258

  3. Miccoli, Roberto

    1. Primary Prevention of Cardiovascular Disease in People With Dysglycemia
      Cristina Bianchi, Roberto Miccoli, Giuseppe Penno and Stefano Del Prato
      Diabetes Care 2008 Feb; 31 (Supplement 2): S208-S214. https://doi.org/10.2337/dc08-s256

  4. Milicevic, Zvonko

    1. Natural History of Cardiovascular Disease in Patients With DiabetesRole of hyperglycemia
      Zvonko Milicevic, Itamar Raz, Scott D. Beattie, Barbara N. Campaigne, Samiha Sarwat, Elwira Gromniak, Irina Kowalska, Edvard Galic, Meng Tan and Markolf Hanefeld
      Diabetes Care 2008 Feb; 31 (Supplement 2): S155-S160. https://doi.org/10.2337/dc08-s240

  5. Mimran, Albert

    1. Microalbuminuria in Type 2 Diabetes and HypertensionA marker, treatment target, or innocent bystander?
      Seema Basi, Pierre Fesler, Albert Mimran and Julia B. Lewis
      Diabetes Care 2008 Feb; 31 (Supplement 2): S194-S201. https://doi.org/10.2337/dc08-s249

  6. Mitrakou, Asimina

    1. Treatment Modalities of ObesityWhat fits whom?
      Vojtĕch Hainer, Hermann Toplak and Asimina Mitrakou
      Diabetes Care 2008 Feb; 31 (Supplement 2): S269-S277. https://doi.org/10.2337/dc08-s265

  7. Monnier, Louis

    1. Glycemic VariabilityShould we and can we prevent it?
      Louis Monnier and Claude Colette
      Diabetes Care 2008 Feb; 31 (Supplement 2): S150-S154. https://doi.org/10.2337/dc08-s241

  8. Morton, John M.

    1. Bariatric Surgery in Patients With Morbid Obesity and Type 2 Diabetes
      Guntram Schernthaner and John M. Morton
      Diabetes Care 2008 Feb; 31 (Supplement 2): S297-S302. https://doi.org/10.2337/dc08-s270

N

  1. Nilsson, Peter M.

    1. Is Weight Loss Beneficial for Reduction of Morbidity and Mortality?What is the controversy about?
      Peter M. Nilsson
      Diabetes Care 2008 Feb; 31 (Supplement 2): S278-S283. https://doi.org/10.2337/dc08-s268

O

  1. Orsini-Federici, Marco

    1. Treatment of Type 2 Diabetes With Combined TherapyWhat are the pros and cons?
      Massimo Massi-Benedetti and Marco Orsini-Federici
      Diabetes Care 2008 Feb; 31 (Supplement 2): S131-S135. https://doi.org/10.2337/dc08-s233

  2. Osher, Etty

    1. Diastolic Pressure in Type 2 DiabetesCan target systolic pressure be reached without “diastolic hypotension”?
      Etty Osher and Naftali Stern
      Diabetes Care 2008 Feb; 31 (Supplement 2): S249-S254. https://doi.org/10.2337/dc08-s262

P

  1. Paravicini, Tamara M.

    1. NADPH Oxidases, Reactive Oxygen Species, and HypertensionClinical implications and therapeutic possibilities
      Tamara M. Paravicini and Rhian M. Touyz
      Diabetes Care 2008 Feb; 31 (Supplement 2): S170-S180. https://doi.org/10.2337/dc08-s247

  2. Penno, Giuseppe

    1. Primary Prevention of Cardiovascular Disease in People With Dysglycemia
      Cristina Bianchi, Roberto Miccoli, Giuseppe Penno and Stefano Del Prato
      Diabetes Care 2008 Feb; 31 (Supplement 2): S208-S214. https://doi.org/10.2337/dc08-s256

  3. Perren, Aurel

    1. Islet Inflammation in Type 2 DiabetesFrom metabolic stress to therapy
      Marc Y. Donath, Desiree M. Schumann, Mirjam Faulenbach, Helga Ellingsgaard, Aurel Perren and Jan A. Ehses
      Diabetes Care 2008 Feb; 31 (Supplement 2): S161-S164. https://doi.org/10.2337/dc08-s243

  4. Phillip, Moshe

    1. Hypoglycemia in Type 1 DiabetesA still unresolved problem in the era of insulin analogs and pump therapy
      Shlomit Shalitin and Moshe Phillip
      Diabetes Care 2008 Feb; 31 (Supplement 2): S121-S124. https://doi.org/10.2337/dc08-s228

  5. Pi-Sunyer, Xavier

    1. Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese PatientsPooled 1-year data from the Rimonabant in Obesity (RIO) program
      Luc Van Gaal, Xavier Pi-Sunyer, Jean-Pierre Després, Christine McCarthy and André Scheen
      Diabetes Care 2008 Feb; 31 (Supplement 2): S229-S240. https://doi.org/10.2337/dc08-s258

  6. Pickup, John C.

    1. Long-Acting Insulin Analogs Versus Insulin Pump Therapy for the Treatment of Type 1 and Type 2 Diabetes
      John C. Pickup and Eric Renard
      Diabetes Care 2008 Feb; 31 (Supplement 2): S140-S145. https://doi.org/10.2337/dc08-s235

  7. Pillar, Giora

    1. Abdominal Fat and Sleep ApneaThe chicken or the egg?
      Giora Pillar and Naim Shehadeh
      Diabetes Care 2008 Feb; 31 (Supplement 2): S303-S309. https://doi.org/10.2337/dc08-s272

  8. Porcellati, Francesca

    1. Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 DiabetesThe role of insulin analogs
      Paolo Rossetti, Francesca Porcellati, Geremia B. Bolli and Carmine G. Fanelli
      Diabetes Care 2008 Feb; 31 (Supplement 2): S113-S120. https://doi.org/10.2337/dc08-s227

R

  1. Raz, Itamar

    1. The Controversies in Obesity, Diabetes and Hypertension (CODHy) MeetingWhat is it all about?
      Itamar Raz and Ram Weiss
      Diabetes Care 2008 Feb; 31 (Supplement 2): S111-S112. https://doi.org/10.2337/dc08-s226
    2. Natural History of Cardiovascular Disease in Patients With DiabetesRole of hyperglycemia
      Zvonko Milicevic, Itamar Raz, Scott D. Beattie, Barbara N. Campaigne, Samiha Sarwat, Elwira Gromniak, Irina Kowalska, Edvard Galic, Meng Tan and Markolf Hanefeld
      Diabetes Care 2008 Feb; 31 (Supplement 2): S155-S160. https://doi.org/10.2337/dc08-s240
    3. Albuminuria: A Great Risk Marker, but an Underestimated Target in Diabetes
      Dick de Zeeuw and Itamar Raz
      Diabetes Care 2008 Feb; 31 (Supplement 2): S190-S193. https://doi.org/10.2337/dc08-s248

  2. Renard, Eric

    1. Long-Acting Insulin Analogs Versus Insulin Pump Therapy for the Treatment of Type 1 and Type 2 Diabetes
      John C. Pickup and Eric Renard
      Diabetes Care 2008 Feb; 31 (Supplement 2): S140-S145. https://doi.org/10.2337/dc08-s235

  3. Riddle, Matthew C.

    1. Combined Therapy With Insulin Plus Oral Agents: Is There Any Advantage?An argument in favor
      Matthew C. Riddle
      Diabetes Care 2008 Feb; 31 (Supplement 2): S125-S130. https://doi.org/10.2337/dc08-s231

  4. Rossetti, Paolo

    1. Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 DiabetesThe role of insulin analogs
      Paolo Rossetti, Francesca Porcellati, Geremia B. Bolli and Carmine G. Fanelli
      Diabetes Care 2008 Feb; 31 (Supplement 2): S113-S120. https://doi.org/10.2337/dc08-s227

  5. Roth, Jesse

    1. Insulin Resistance and HyperinsulinemiaIs hyperinsulinemia the cart or the horse?
      Michael H. Shanik, Yuping Xu, Jan Škrha, Rachel Dankner, Yehiel Zick and Jesse Roth
      Diabetes Care 2008 Feb; 31 (Supplement 2): S262-S268. https://doi.org/10.2337/dc08-s264

  6. Rubino, Francesco

    1. Is Type 2 Diabetes an Operable Intestinal Disease?A provocative yet reasonable hypothesis
      Francesco Rubino
      Diabetes Care 2008 Feb; 31 (Supplement 2): S290-S296. https://doi.org/10.2337/dc08-s271

S

  1. Sarwat, Samiha

    1. Natural History of Cardiovascular Disease in Patients With DiabetesRole of hyperglycemia
      Zvonko Milicevic, Itamar Raz, Scott D. Beattie, Barbara N. Campaigne, Samiha Sarwat, Elwira Gromniak, Irina Kowalska, Edvard Galic, Meng Tan and Markolf Hanefeld
      Diabetes Care 2008 Feb; 31 (Supplement 2): S155-S160. https://doi.org/10.2337/dc08-s240

  2. Scheen, André

    1. Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese PatientsPooled 1-year data from the Rimonabant in Obesity (RIO) program
      Luc Van Gaal, Xavier Pi-Sunyer, Jean-Pierre Després, Christine McCarthy and André Scheen
      Diabetes Care 2008 Feb; 31 (Supplement 2): S229-S240. https://doi.org/10.2337/dc08-s258

  3. Schernthaner, Guntram

    1. Bariatric Surgery in Patients With Morbid Obesity and Type 2 Diabetes
      Guntram Schernthaner and John M. Morton
      Diabetes Care 2008 Feb; 31 (Supplement 2): S297-S302. https://doi.org/10.2337/dc08-s270

  4. Schnell, Oliver

    1. Insulin as a First-Line Therapy in Type 2 DiabetesShould the use of sulfonylureas be halted?
      Eberhard Standl and Oliver Schnell
      Diabetes Care 2008 Feb; 31 (Supplement 2): S136-S139. https://doi.org/10.2337/dc08-s234

  5. Schumann, Desiree M.

    1. Islet Inflammation in Type 2 DiabetesFrom metabolic stress to therapy
      Marc Y. Donath, Desiree M. Schumann, Mirjam Faulenbach, Helga Ellingsgaard, Aurel Perren and Jan A. Ehses
      Diabetes Care 2008 Feb; 31 (Supplement 2): S161-S164. https://doi.org/10.2337/dc08-s243

  6. Senges, Jochen

    1. Should We Prescribe Statin and Aspirin for Every Diabetic Patient?Is it time for a polypill?
      Harm Wienbergen, Jochen Senges and Anselm K. Gitt
      Diabetes Care 2008 Feb; 31 (Supplement 2): S222-S225. https://doi.org/10.2337/dc08-s253

  7. Shalitin, Shlomit

    1. Hypoglycemia in Type 1 DiabetesA still unresolved problem in the era of insulin analogs and pump therapy
      Shlomit Shalitin and Moshe Phillip
      Diabetes Care 2008 Feb; 31 (Supplement 2): S121-S124. https://doi.org/10.2337/dc08-s228

  8. Shanik, Michael H.

    1. Insulin Resistance and HyperinsulinemiaIs hyperinsulinemia the cart or the horse?
      Michael H. Shanik, Yuping Xu, Jan Škrha, Rachel Dankner, Yehiel Zick and Jesse Roth
      Diabetes Care 2008 Feb; 31 (Supplement 2): S262-S268. https://doi.org/10.2337/dc08-s264

  9. Shehadeh, Naim

    1. Abdominal Fat and Sleep ApneaThe chicken or the egg?
      Giora Pillar and Naim Shehadeh
      Diabetes Care 2008 Feb; 31 (Supplement 2): S303-S309. https://doi.org/10.2337/dc08-s272

  10. Škrha, Jan

    1. Insulin Resistance and HyperinsulinemiaIs hyperinsulinemia the cart or the horse?
      Michael H. Shanik, Yuping Xu, Jan Škrha, Rachel Dankner, Yehiel Zick and Jesse Roth
      Diabetes Care 2008 Feb; 31 (Supplement 2): S262-S268. https://doi.org/10.2337/dc08-s264

  11. Standl, Eberhard

    1. Insulin as a First-Line Therapy in Type 2 DiabetesShould the use of sulfonylureas be halted?
      Eberhard Standl and Oliver Schnell
      Diabetes Care 2008 Feb; 31 (Supplement 2): S136-S139. https://doi.org/10.2337/dc08-s234

  12. Stern, Naftali

    1. Diastolic Pressure in Type 2 DiabetesCan target systolic pressure be reached without “diastolic hypotension”?
      Etty Osher and Naftali Stern
      Diabetes Care 2008 Feb; 31 (Supplement 2): S249-S254. https://doi.org/10.2337/dc08-s262

  13. Stirban, Alin O.

    1. Cardiovascular Complications in DiabetesTargets and interventions
      Alin O. Stirban and Diethelm Tschoepe
      Diabetes Care 2008 Feb; 31 (Supplement 2): S215-S221. https://doi.org/10.2337/dc08-s257
    2. Should We Be More Aggressive in the Therapy Against Cardiovascular Risk Factors?Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill?
      Alin O. Stirban and Diethelm Tschoepe
      Diabetes Care 2008 Feb; 31 (Supplement 2): S226-S228. https://doi.org/10.2337/dc08-s254

T

  1. Tan, Meng

    1. Natural History of Cardiovascular Disease in Patients With DiabetesRole of hyperglycemia
      Zvonko Milicevic, Itamar Raz, Scott D. Beattie, Barbara N. Campaigne, Samiha Sarwat, Elwira Gromniak, Irina Kowalska, Edvard Galic, Meng Tan and Markolf Hanefeld
      Diabetes Care 2008 Feb; 31 (Supplement 2): S155-S160. https://doi.org/10.2337/dc08-s240

  2. Tomkin, Gerald H.

    1. Targets for Intervention in Dyslipidemia in Diabetes
      Gerald H. Tomkin
      Diabetes Care 2008 Feb; 31 (Supplement 2): S241-S248. https://doi.org/10.2337/dc08-s260

  3. Toplak, Hermann

    1. Treatment Modalities of ObesityWhat fits whom?
      Vojtĕch Hainer, Hermann Toplak and Asimina Mitrakou
      Diabetes Care 2008 Feb; 31 (Supplement 2): S269-S277. https://doi.org/10.2337/dc08-s265

  4. Touyz, Rhian M.

    1. NADPH Oxidases, Reactive Oxygen Species, and HypertensionClinical implications and therapeutic possibilities
      Tamara M. Paravicini and Rhian M. Touyz
      Diabetes Care 2008 Feb; 31 (Supplement 2): S170-S180. https://doi.org/10.2337/dc08-s247

  5. Tschoepe, Diethelm

    1. Cardiovascular Complications in DiabetesTargets and interventions
      Alin O. Stirban and Diethelm Tschoepe
      Diabetes Care 2008 Feb; 31 (Supplement 2): S215-S221. https://doi.org/10.2337/dc08-s257
    2. Should We Be More Aggressive in the Therapy Against Cardiovascular Risk Factors?Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill?
      Alin O. Stirban and Diethelm Tschoepe
      Diabetes Care 2008 Feb; 31 (Supplement 2): S226-S228. https://doi.org/10.2337/dc08-s254

V

  1. Van Gaal, Luc

    1. Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese PatientsPooled 1-year data from the Rimonabant in Obesity (RIO) program
      Luc Van Gaal, Xavier Pi-Sunyer, Jean-Pierre Després, Christine McCarthy and André Scheen
      Diabetes Care 2008 Feb; 31 (Supplement 2): S229-S240. https://doi.org/10.2337/dc08-s258

W

  1. Weiss, Ram

    1. Metabolic Complications of Childhood ObesityIdentifying and mitigating the risk
      Ram Weiss and Francine Ratner Kaufman
      Diabetes Care 2008 Feb; 31 (Supplement 2): S310-S316. https://doi.org/10.2337/dc08-s273
    2. The Controversies in Obesity, Diabetes and Hypertension (CODHy) MeetingWhat is it all about?
      Itamar Raz and Ram Weiss
      Diabetes Care 2008 Feb; 31 (Supplement 2): S111-S112. https://doi.org/10.2337/dc08-s226

  2. Wienbergen, Harm

    1. Should We Prescribe Statin and Aspirin for Every Diabetic Patient?Is it time for a polypill?
      Harm Wienbergen, Jochen Senges and Anselm K. Gitt
      Diabetes Care 2008 Feb; 31 (Supplement 2): S222-S225. https://doi.org/10.2337/dc08-s253

  3. Wolpert, Howard A.

    1. The Nuts and Bolts of Achieving End Points With Real-Time Continuous Glucose Monitoring
      Howard A. Wolpert
      Diabetes Care 2008 Feb; 31 (Supplement 2): S146-S149. https://doi.org/10.2337/dc08-s238

  4. Wynne, Katie

    1. Can Gut Hormones Control Appetite and Prevent Obesity?
      Owais B. Chaudhri, Katie Wynne and Stephen R. Bloom
      Diabetes Care 2008 Feb; 31 (Supplement 2): S284-S289. https://doi.org/10.2337/dc08-s269

X

  1. Xu, Xiulong

    1. Abnormal Glomerular Permeability Characteristics in Diabetic NephropathyImplications for the therapeutic use of low–molecular weight heparin
      Edmund J. Lewis and Xiulong Xu
      Diabetes Care 2008 Feb; 31 (Supplement 2): S202-S207. https://doi.org/10.2337/dc08-s251

  2. Xu, Yuping

    1. Insulin Resistance and HyperinsulinemiaIs hyperinsulinemia the cart or the horse?
      Michael H. Shanik, Yuping Xu, Jan Škrha, Rachel Dankner, Yehiel Zick and Jesse Roth
      Diabetes Care 2008 Feb; 31 (Supplement 2): S262-S268. https://doi.org/10.2337/dc08-s264

Z

  1. Zick, Yehiel

    1. Insulin Resistance and HyperinsulinemiaIs hyperinsulinemia the cart or the horse?
      Michael H. Shanik, Yuping Xu, Jan Škrha, Rachel Dankner, Yehiel Zick and Jesse Roth
      Diabetes Care 2008 Feb; 31 (Supplement 2): S262-S268. https://doi.org/10.2337/dc08-s264
Back to top